Exploratory Safety and Efficacy of EMP-01 in Social Anxiety Disorder

Clinical trial NCT06693609 · COMPLETED

Trial details

NCT number: NCT06693609
Sponsor: atai Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Social Anxiety Disorder

Start date: 2025-05-08
Primary completion: 2025-12-10
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.